Comprehensive Guidelines for Authors
The following directions should be taken into account when writing an article for the Biotechnology and Development Monitor.

In general, an article should present a critical overview and try to give the different outlooks and/or opinions. The model to which Monitor articles are structured, is as follows:
  • General introduction to the theme of the article (about 60 words). The editors may modify the introduction according to their requirements.
  • Introduction to the problem under discussion. For example, an article about abiotic stress should first explain the magnitude of the problem of abiotic stress. An article about maize should first explain who produces it, who consumes it and why it is important. An article about a country should first explain the general problems of that country in relation to the biotechnological applications later presented. The problem and the possible solutions should also be put in perspective: for example, it should be explained what other methods/technologies than biotechnology have been tried in solving the problem, why biotechnology is thought to provide a superior solution, or/and under what conditions biotechnology might pose problems.
  • Biotechnological applications: what is the state of the art in the area of biotechnology?
  • Conclusion: depending on the subject of the article, the following questions could be answered: who will benefit from the technologies in what way, and who will not? What are the consequences of the development described? Will a programme be useful? How are the priorities of a programme set? What are the positive or negative elements of the programme?
After an article is submitted, several editorial rounds will follow in which the editors will consult different experts. Any substantial changes, with the exception of the introduction, will be discussed with the author(s).
Finally, it should be remembered that the Monitor is written for scientists and non-scientists, which means that the concepts used or processes/products described should be clear to both groups. Therefore, please try to avoid making references to processes, products or concepts without any explanation.
  1. Newcastle's disease. This can be explained as the most important virus disease of poultry in the world.
  2. Restriction fragment length polymorphism (RFLP) markers. This might be explained as a method to identify and select single-gene traits associated with stress tolerance.

  • One published Monitor page is about 1000 words. A Page 24 article is about 850 words, of which the introduction is 60 words.
  • Every author should provide her or his position and contact address.
  • Every abbreviation should be explained and every name should be in italics when first mentioned.
"In January 1993 the African Centre for Technology Studies (ACTS) and the Stockholm Environment Institute (SEI) (...)"
a. When names of institutes, companies etc. are used, their country of origin should be indicated.
Also Calgene, USA, has started a project aimed at developing blue cotton.
No references are used in articles. At the end of an article about 5 references may be listed. This concerns books/articles/resource persons that have been highly important to the article.

Reviews should contain about 600 words.

The editors prefer the articles/reviews to be presented on diskette or transferred through E-mail, but also accept letters or faxes. Whenever possible, correspondence is made by E-mail.

We pay a moderate author's fee. Payments will be made in Euros equalling 150 per book review or per 1000 published words of a regular article.
If you do not live in the Netherlands please send the following data along with the article/review: full name; date of birth; full address; name of bank; bank account number; bank address, and SWIFT code (required for international money transfer; please enquire at your bank branch). If you do live in the Netherlands we will send you the relevant forms to fill in.
For questions concerning payment, contact Jacqueline Rebel, administrative officer.
Rejected material will be returned if the address directions are clear.
The material published is free of copyright.

Biotechnology and Development Monitor
Nijenburg 2a
1081 GG Amsterdam
The Netherlands
phone: (+31) 20 - 504 0008
fax: (+31) 20 - 442 0977